HomeCompareFRTA vs JNJ

FRTA vs JNJ: Dividend Comparison 2026

FRTA yields 8.33% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRTA wins by $4.4K in total portfolio value
10 years
FRTA
FRTA
● Live price
8.33%
Share price
$24.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.7K
Annual income
$1,411.18
Full FRTA calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — FRTA vs JNJ

📍 FRTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRTAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRTA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRTA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRTA
Annual income on $10K today (after 15% tax)
$708.33/yr
After 10yr DRIP, annual income (after tax)
$1,199.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $2,786.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRTA + JNJ for your $10,000?

FRTA: 50%JNJ: 50%
100% JNJ50/50100% FRTA
Portfolio after 10yr
$32.5K
Annual income
$3,050.29/yr
Blended yield
9.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FRTA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRTA buys
0
JNJ buys
0
No recent congressional trades found for FRTA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRTAJNJ
Forward yield8.33%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$34.7K$30.3K
Annual income after 10y$1,411.18$4,689.40
Total dividends collected$11.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FRTA vs JNJ ($10,000, DRIP)

YearFRTA PortfolioFRTA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,533$833.33$10,592$272.30+$941.00FRTA
2$13,239$898.23$11,289$357.73+$1.9KFRTA
3$15,129$963.61$12,123$472.89+$3.0KFRTA
4$17,217$1,029.16$13,141$629.86+$4.1KFRTA
5$19,517$1,094.59$14,408$846.81+$5.1KFRTA
6$22,043$1,159.63$16,021$1,151.60+$6.0KFRTA
7$24,810$1,224.02$18,122$1,588.22+$6.7KFRTA
8$27,834$1,287.54$20,930$2,228.20+$6.9KFRTA
9$31,133$1,349.99$24,792$3,191.91+$6.3KFRTA
10$34,723$1,411.18$30,274$4,689.40+$4.4KFRTA

FRTA vs JNJ: Complete Analysis 2026

FRTAStock

Forterra, Inc., through its subsidiaries, manufactures and sells pipe and precast products in the United States, Canada, and Mexico. It operates through Drainage Pipe & Products; and Water Pipe & Products segments. The company offers concrete drainage pipes used for storm water applications, residential and non-residential site developments, sanitary sewers, low-pressure sewer force mains, tunneled systems, treatment plant piping, and utility tunnels; precast concrete products, including box culverts, utility vaults, manholes, drainage inlets, and pipe end sections used for roadway and airport drainage, storm water management, utility construction, and water treatment and filtration systems; and architectural panels for buildings, modular railroad crossings, retaining wall and storm water treatment systems, highway noise barriers, and concrete vaults that are used to house dry or wet utilities. It also provides hollow-core planks, prestressed bridge girders, beams, columns, wall panels, stairs, garage floors, and architectural claddings for parking garages and arched and modular bridges; precast concrete bridge girders for highway projects; precast concrete foundation to support prefabricated shelters or equipment buildings; precast product that consolidates and protects underground electrical and communication cables; and storm water technologies for storm water management market. In addition, the company offers ductile iron pipes for transmission and distribution of potable and wastewater; concrete pressure pipes for water transmission and distribution, power plant cooling water lines, sewage force mains for waste and storm water, and other applications; and prestressed concrete and bar-wrapped concrete pipes. The company was founded in 1899 and is headquartered in Irving, Texas. As of March 18, 2022, Forterra, Inc. operates as a subsidiary of Quikrete Holdings, Inc.

Full FRTA Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FRTA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRTA vs SCHDFRTA vs JEPIFRTA vs OFRTA vs KOFRTA vs MAINFRTA vs ABBVFRTA vs MRKFRTA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.